Omeros Correlations
OMER Stock | USD 8.62 0.22 2.49% |
The current 90-days correlation between Omeros and Oric Pharmaceuticals is -0.07 (i.e., Good diversification). The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Omeros Correlation With Market
Average diversification
The correlation between Omeros and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Omeros and DJI in the same portfolio, assuming nothing else is changed.
Omeros |
Moving against Omeros Stock
0.8 | GNFT | Genfit | PairCorr |
0.76 | VALN | Valneva SE ADR Upward Rally | PairCorr |
0.73 | UPC | Universe Pharmaceuticals | PairCorr |
0.69 | ME | 23Andme Holding | PairCorr |
0.62 | XWEL | XWELL Inc | PairCorr |
0.57 | JNJ | Johnson Johnson | PairCorr |
0.52 | HCM | HUTCHMED DRC | PairCorr |
0.51 | OCEAW | Ocean Biomedical | PairCorr |
0.42 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
0.38 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
0.76 | AMGN | Amgen Inc Earnings Call This Week | PairCorr |
0.74 | SHPH | Shuttle Pharmaceuticals | PairCorr |
0.69 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.68 | PRPH | ProPhase Labs | PairCorr |
0.67 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.6 | APGE | Apogee Therapeutics, | PairCorr |
0.56 | AQST | Aquestive Therapeutics | PairCorr |
0.49 | ABBV | AbbVie Inc Buyout Trend | PairCorr |
0.7 | SYRE | Spyre Therapeutics | PairCorr |
0.63 | TTOO | T2 Biosystms | PairCorr |
0.63 | ENSG | Ensign Group | PairCorr |
0.62 | AVDL | Avadel Pharmaceuticals | PairCorr |
0.5 | TCRX | Tscan Therapeutics | PairCorr |
0.42 | TOVX | Theriva Biologics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Omeros Stock performing well and Omeros Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Omeros' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CRNX | 2.34 | (0.62) | 0.00 | (0.47) | 0.00 | 3.10 | 21.52 | |||
ENTA | 2.77 | (1.31) | 0.00 | (1.15) | 0.00 | 6.95 | 30.73 | |||
FOLD | 1.37 | (0.36) | 0.00 | (0.38) | 0.00 | 2.33 | 11.40 | |||
CERE | 0.77 | 0.07 | (0.01) | 12.08 | 0.94 | 1.91 | 6.40 | |||
CNTB | 3.87 | (0.13) | 0.00 | 0.21 | 0.00 | 8.66 | 29.84 | |||
LGND | 2.19 | 0.07 | 0.01 | 0.19 | 3.22 | 4.64 | 17.92 | |||
PASG | 6.88 | 0.46 | 0.04 | (1.44) | 6.85 | 20.97 | 84.39 | |||
ORIC | 3.71 | 0.34 | 0.08 | 0.31 | 4.22 | 8.04 | 22.87 | |||
LYEL | 4.65 | (0.83) | 0.00 | (0.90) | 0.00 | 11.63 | 36.92 | |||
DSGN | 4.39 | (0.06) | 0.00 | (0.13) | 0.00 | 8.72 | 33.11 |
Omeros Corporate Management
Peter JD | General VP | Profile | |
Nadia Dac | VP Officer | Profile | |
Debra MT | Chief Officer | Profile | |
David Ghesquiere | Chief Officer | Profile | |
Andreas MD | Chief Officer | Profile | |
Gregory MD | Chairman, CoFounder | Profile |